Sergey Nikulin

Dr. Sergey Nikulin


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2020 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PDF file
TGTatiana Gerasimenko
Tatiana Gerasimenko
SNSergey Nikulin
Sergey Nikulin
GZGalina Zakharova
Galina Zakharova
APAndrey Poloznikov
Andrey Poloznikov
VPVladimir Petrov
Vladimir Petrov
ATAlexander Tonevitsky
Alexander Tonevitsky
In contrast to traditional 2D cell cultures, both 3D models and organ-on-a-chip devices allow the study of the physiological responses of human cells. These models reconstruct human tissues in conditions closely resembling the body. Translation of these techniques into practice is hindered by associated labor costs, a need which may be remedied by automation. Impedance spectroscopy (IS) is a promising, automation-compatible label-free technology allowing to carry out a wide range of measurements both in real-time and as endpoints. IS has been applied to both the barrier cultures and the 3D constructs. Here we provide an overview of the impedance-based analysis in different setups and discuss its utility for organ-on-a-chip devices. Most attractive features of impedance-based assays are their compatibility with high-throughput format and supports for the measurements in real time with high temporal resolution, which allow tracing of the kinetics. As of now, IS-based techniques are not free of limitations, including imperfect understanding of the parameters that have their effects on the impedance, especially in 3D cell models, and relatively high cost of the consumables. Moreover, as the theory of IS stems from electromagnetic theory and is quite complex, work on popularization and explanation of the method for experimental biologists is required. It is expected that overcoming these limitations will lead to eventual establishing IS based systems as a standard for automated management of cell-based experiments in both academic and industry environments.

1 November 2017 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
VMVitalii V. Mutsenko
Vitalii V. Mutsenko
OGOleksandr Gryshkov
Oleksandr Gryshkov
LLLothar Lauterboeck
Lothar Lauterboeck
OROlena Rogulska
Olena Rogulska
DTDmitriy N. Tarusin
Dmitriy N. Tarusin
HEHermann Ehrlich
Hermann Ehrlich

1 November 2017 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
VMVitalii V. Mutsenko
Vitalii V. Mutsenko
VBVasilii V. Bazhenov
Vasilii V. Bazhenov
OROlena Rogulska
Olena Rogulska
DTDmitriy N. Tarusin
Dmitriy N. Tarusin
KSKathleen Schütz
Kathleen Schütz
HEHermann Ehrlich
Hermann Ehrlich

17 January 2018 in ACS Chemical Neuroscience
Verified
Journal Article
Closed access
IGIrina N. Gaisina
Irina N. Gaisina
SLSue H. Lee
Sue H. Lee
NKNavneet A. Kaidery
Navneet A. Kaidery
MAManel Ben Aissa
Manel Ben Aissa
MAManuj Ahuja
Manuj Ahuja
IGIrina G. Gazaryan
Irina G. Gazaryan

1 July 2020 in Biochimie
Verified
Journal Article
Closed access
DMDiana V Maltseva
Diana V Maltseva
MRMaria Raigorodskaia
Maria Raigorodskaia
EKEvgeny Knyazev
Evgeny Knyazev
VZVictor Zgoda
Victor Zgoda
OTOlga Tikhonova
Olga Tikhonova
Alexander TonevitskyAlexander Tonevitsky
Alexander Tonevitsky

13 January 2023 in Frontiers in Molecular Biosciences
Verified
Journal Article
Open access
SNSergey Nikulin
Sergey Nikulin
ARAlexandra Razumovskaya
Alexandra Razumovskaya
APAndrey Poloznikov
Andrey Poloznikov
GZGalina Zakharova
Galina Zakharova
BABoris Alekseev
Boris Alekseev
ATAlexander Tonevitsky
Alexander Tonevitsky
Introduction: Relapse of breast cancer is one of the key obstacles to successful treatment. Previously we have shown that low expression of ELOVL5 and IGFBP6 genes in breast cancer tissue corresponded to poor prognosis. ELOVL5 participates directly in the elongation of polyunsaturated fatty acids (PUFAs) that are considered to play an important role in cancer cell metabolism. Thus, in this work we studied the changes in lipid metabolism in breast cancer cells with reduced expression of either ELOVL5 or IGFBP6 gene.Methods: MDA-MB-231 cells with a stable knockdown of either ELOVL5 or IGFBP6 gene were used in this study. Transcriptomic and proteomic analysis as well as RT-PCR were utilized to assess gene expression. Content of individual fatty acids in the cells was measured with HPLC-MS. HPLC was used for analysis of the kinetics of PUFAs uptake. Cell viability was measured with MTS assay. Flow cytometry was used to measure activation of apoptosis. Fluorescent microscopy was utilized to assess accumulation of ROS and formation of lipid droplets. Glutathione peroxidase activity was measured with a colorimetric assay.Results: We found that the knockdown of IGFBP6 gene led to significant changes in the profile of fatty acids in the cells and in the expression of many genes associated with lipid metabolism. As some PUFAs are known to inhibit proliferation and cause death of cancer cells, we also tested the response of the cells to single PUFAs and to combinations of docosahexaenoic acid (DHA, a n-3 PUFA) with standard chemotherapeutic drugs. Our data suggest that external PUFAs cause cell death by activation of ferroptosis, an iron-dependent mechanism of cell death with excessive lipid peroxidation. Moreover, both knockdowns increased cells’ sensitivity to ferroptosis, probably due to a significant decrease in the activity of the antioxidant enzyme GPX4. Addition of DHA to commonly used chemotherapeutic drugs enhanced their effect significantly, especially for the cells with low expression of IGFBP6 gene.Discussion: The results of this study suggest that addition of PUFAs to the treatment regimen for the patients with low expression of IGFBP6 and ELOVL5 genes can be potentially beneficial and is worth testing in a clinically relevant setting.